PDCD1 and cancer: Mechanistically, the TME influences cancer cells via complicated and dynamic pathways to regulate cancer-related signaling5, involving ligand–receptor interactions (e.g., PD-L1 of cancer cells binding to PD1 of T cells), cytokine/metabolite responses, and deposition of extracellular matrix (ECM)6–10.